BPC is excited to share an exclusive interview with George Karafotias, CEO of Wellnex Life(ASX: WNX).

Key Highlights:

1. Wellnex Life achieved record profitability, with over $2 million in branded sales for April. Margins increased from 11% to close to 40%.

2. The acquisition of PainAway contributed to this profitability, along with the organic growth of other brands within the company, which are experiencing consistent month-on-month growth.

A huge congratulations to George Karafotias, Zack Bozinovski, the board and the team at WNX for reaching this exciting milestone!

Read the Conversation:

James Whelan here, Managing Director of Barclay Pierce Capital's Wealth Management Team, joined here by George Karafotias of Wellnex Ltd. And an announcement last week, George, I'm just going to let you speak to it. Profitability? Profitability in April of over 300, 000. Brand sales over 200, 000. 2 million for the month, which is a record and it was like, we're going to be growing month on month from now to the end of the year.

Um, and best thing is margins from 11% last year to close to 40%, which has really pushed us to be that profitable company we're looking at. Excellent. And that's off the, mostly off the acquisition of pain away or is it with some other stuff? Yep. The acquisition of PainAway has definitely helped us achieve that profitability, but also the organic growth of all our other brands, which while they're still young. 

Excellent. Thank you very much for that, George. Well done on that. And we'll come back to you with some more updates later as they come up. But very well done, Wellnex on that one. WNX, stock code. My name is James Whelan, Managing Director of Barclay Peters Capital's Wealth Management Team. And with a quick update with one of the companies we follow very closely, George Karafotias of Wellnex.